8.23
0.00
(0.00%)
At close: April 14 at 4:02:32 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 8 | 8 | 16 | 13 |
Avg. Estimate | 35.27B | 42.36B | 168.18B | 170.74B |
Low Estimate | 32.49B | 38.5B | 155.34B | 151.01B |
High Estimate | 39.12B | 44.92B | 177.2B | 178.86B |
Year Ago Sales | 39.89B | 44.81B | 172.71B | 168.18B |
Sales Growth (year/est) | -11.59% | -5.48% | -2.62% | 1.52% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
FMC1D.XC | -- | -- | -- | -- |
S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
Maintains | Barclays: Equal-Weight to Equal-Weight | 4/15/2025 |
Maintains | UBS: Neutral to Neutral | 4/10/2025 |
Downgrade | Goldman Sachs: Buy to Neutral | 4/10/2025 |
Downgrade | Bernstein: Market Perform to Underperform | 4/9/2025 |
Maintains | JP Morgan: Overweight to Overweight | 3/27/2025 |
Maintains | Piper Sandler: Neutral to Neutral | 3/20/2025 |